New York cannabis regulators unveiled sweeping changes across multiple industry sectors, approving 125 new business licenses while introducing payment flexibility for medical operators and extending deadlines for social equity retailers. The state’s Cannabis Control Board on Tuesday approved: 42 retail dispensaries 30 microbusinesses 6 cultivators 11 distributors 36 processors Regulators …
Cannabis delivery giant Eaze secured $10 million in Series B funding to restart operations across four states, an unexpected revival that comes just weeks after its owners announced plans to wind down the business by year-end. The newly formed company plans to reopen 70 locations, including 57 retail stores, according …
“This survey’s findings are an important addition to the growing body of literature suggesting that, in some instances, cannabis may act as an intervention for people seeking to reduce their alcohol consumption.” The post Marijuana Consumers Frequently Report Substituting Cannabis for Alcohol, Other Substances appeared first on NORML.
Enveric Biosciences (NASDAQ: ENVB) agreed to license one of its experimental psychedelic drug candidates to MycoMedica Life Sciences in a deal worth as much as $62 million, as the biotech company keeps its eye on its non-hallucinogenic treatments. The agreement grants MycoMedica exclusive global rights to EB-002, a synthetic prodrug …